Popular Blood Pressure Medication Recalled Due to Potential Cancer Risk
July 18th, 2018|
At Ferrer, Poirot & Wansbrough, we know that many of the most popular prescription medications can be recalled or subject to new warnings at any time.
That scenario played out last week when a generic blood pressure and heart failure medication called valsartan was recalled by the U.S. Food and Drug Administration (FDA) due to concerns that it may be tainted by a potentially carcinogenic compound called N-nitrosodimethylamine (NDMA).
The FDA issued the following information to patients and healthcare professionals concerning the usage of valsartan:
- Patients currently taking the medication should continue usage for now—Valsartan is used to treat potentially life-threatening conditions, so patients shouldn’t stop taking it without speaking to their healthcare providers or receiving alternative treatments.
- Affected medications are manufactured in China and distributed by three companies in the U.S.—Potentially tainted valsartan medications are manufactured by Zhejiang Huahai Pharmaceutical Co. Ltd. In China and are distributed in the U.S. by three companies: Major Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Solco Healthcare. Patients can check the drug and company names on their medication bottles or packaging to determine if their prescription is subject to the recall.
Our drug injury lawyers will be keeping a close eye on this recall and how both the drug manufacturer and its U.S.-based distributors move forward in the coming days and weeks.
If you or someone you love was injured by valsartan or another potentially dangerous medication, we want to speak with you. Call today for a free consultation to find out how we can put our years of experience to work for you.